ratiopharm GmbH Sustainability Profile
ratiopharm GmbH, a prominent player in the pharmaceutical industry, is headquartered in Ulm, Germany. Founded in 1990, the company has established itself as a leading provider of generic medications, focusing on high-quality, affordable healthcare solutions. With a strong presence across Europe, ratiopharm is dedicated to enhancing patient access to essential medicines. The company’s core offerings include a wide range of generic drugs, over-the-counter products, and specialty pharmaceuticals, all characterised by rigorous quality standards and competitive pricing. ratiopharm's commitment to innovation and sustainability has earned it a notable position in the market, recognised for its contributions to public health and patient care. As a trusted name in pharmaceuticals, ratiopharm continues to expand its portfolio, ensuring that effective treatments are accessible to all.
DitchCarbon Score
How does ratiopharm GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ratiopharm GmbH's score of 79 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ratiopharm GmbH, headquartered in Germany, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Teva Pharmaceutical Industries Limited, which influences its climate commitments and emissions reporting. As part of its parent company's sustainability initiatives, ratiopharm GmbH adheres to reduction targets set by Teva Pharmaceutical Industries Limited. These targets are aligned with the Science Based Targets initiative (SBTi) and are part of a broader commitment to reduce greenhouse gas emissions across its operations. However, specific reduction targets or achievements for ratiopharm GmbH itself have not been disclosed. The emissions data and performance metrics are cascaded from Teva Pharmaceutical Industries Limited, which is responsible for the overarching climate strategy and reporting. This relationship ensures that ratiopharm GmbH is integrated into a larger framework of sustainability efforts, although individual emissions figures for ratiopharm GmbH remain unspecified. In summary, while ratiopharm GmbH is committed to climate action through its association with Teva Pharmaceutical Industries Limited, detailed emissions data and specific reduction targets for the company are currently unavailable.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 438,420,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 613,541,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is ratiopharm GmbH's Industry?
How Carbon Intensive is ratiopharm GmbH's Location?
ratiopharm GmbH's Scope 3 Categories Breakdown
ratiopharm GmbH's Scope 3 emissions, which decreased by 6% last year and decreased by approximately 24% since 2020, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 61% of Scope 3 emissions.
Top Scope 3 Categories
ratiopharm GmbH's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
ratiopharm GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
